Interview with Johannes Setijono , President Commissioner, Kolbe
You have been working at Kalbe for 38 years, and as President Director for 11 years. What has it been like to see the firm transform from a company based…
Providing value added products and caring for the customers are the key success factors of Metiska for over the past 26 years in the pharmaceutical industry.
Moving forward, they hope to push the boundaries of medicine in Indonesia, with a focus on high-end innovative products, unique formulations and value-added presentations.
They want to be the preferred partner of medical professionals, and we actively seek business partners who share the same vision of medicine as us.
Internally they constantly train their staff to become better professionals and will always welcome excited and motivated people to join the team.
http://www.metiska.co.id/home.html
HEAD OFFICE
Jl. Kebayoran Lama No. 557
Jakarta 12220, Indonesia
Telephone : +6221 720-2351 / 722-0076
Fax : +6221 725-0889
Email : info@metiska.co.id
You have been working at Kalbe for 38 years, and as President Director for 11 years. What has it been like to see the firm transform from a company based…
What role does Indonesia play within Quintiles’ Asian operations? Quintiles has been growing dramatically across the South East Asian Region, which comprises Philippines, Singapore, Thailand, Malaysia, Vietnam and Indonesia as…
Pyridam Farma has achieved and maintained the leading position in terms of growth in the Indonesian pharmaceutical industry for two years. What strategic choices have caused Pyridam to outperform its…
Overall health indicators have improved significantly in Indonesia in recent years. However, the country still faces many challenges and there are many areas in need of further improvement. What is…
Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the…
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being a part of Zuellig…
Many multinational companies have chosen to forgo establishing production facilities in Indonesia or have even shuttered their facilities, as did Janssen-Cilag. With the recent 10/10 decree, it seems the environment…
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
How has the increasing international integration of the Indonesian economy influenced the challenges and transformations the BPOM went through in the past 9 years since its reorganization? The constant changes…
Millennium Pharmacon International has a long history, starting at its founding in 1952. Could you give our readers an overview of the company’s milestones, particularly those from the past decade?…
While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on…
See our Cookie Privacy Policy Here